FDA recall record

Beekley Medical 0-SPOT Mammography Skin Markers REF 652 recall — FDA Z-2309-2017

Mammography Skin Marker 0 -SPOT (REF 652) product was mis-labeled with A-SPOT (REF 651) labels

Class IIIclassification
Z-2309-2017official record ID
Jun 14, 2017report date

Recall record at a glance

Official recordZ-2309-2017
CategoryMedical Device Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBeekley Corporation
Report dateJun 14, 2017
Recall initiation dateMay 8, 2017
Quantity104 boxes (58/box)= 6,032 total units
LocationBristol, CT, United States

Official product description

Beekley Medical 0-SPOT Mammography Skin Markers REF 652

Why the product was recalled

Mammography Skin Marker 0 -SPOT (REF 652) product was mis-labeled with A-SPOT (REF 651) labels

Distribution information

US Distribution to the states of : AR, CA GA, IL, TX, MN, NV, NY, WI., and Internationally to Canada.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.